Shifting Burden from Mortality to Morbidity: Global Trends and Disparities in Colorectal Cancer Years Lived with Disability, 1990–2023
Preprint
- 12 November 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: As survival after colorectal cancer improves, more patients live with the consequences of the disease and its treatment, yet years lived with disability (YLDs) are rarely analysed as a primary outcome. We examined whether the colorectal cancer burden is shifting from premature death towards life with disability. Methods: Using Global Burden of Disease (GBD) 2023 estimates for the world, the five Socio-demographic Index (SDI) quintiles and China, we analysed YLDs, years of life lost (YLLs) and the age-standardised YLD share of disability-adjusted life-years (morbidity share) from 1990 to 2023 with joinpoint regression, and decomposed the change in YLD counts into population growth, population ageing and change in age-specific rates. Results: Global YLDs rose from 434,965 to 1,125,290 (+158.7%); the age-standardised YLD rate rose by 10.5% while the YLL rate fell by 22.1%. The morbidity share increased from 3.06% to 4.28% globally and from 2.06% to 4.69% in China, which overtook the global level in 2018. A rising YLD rate with a falling YLL rate was found globally, in the two higher SDI quintiles and in China; in the three lower quintiles both rates rose. The global increase in the YLD rate was confined to men (+19.8%; women −1.5%). Population growth and ageing accounted for 43.4% and 45.9% of the global increase in YLD counts. Conclusions: In higher-SDI settings and in China, the colorectal cancer burden is shifting from premature death towards life with disability, whereas in lower-SDI settings both components are still rising. Survivorship services should be planned for a disability burden concentrated among men and older adults.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- The rising disabling share of health loss among adults aged 80 years and older: A 34-year GBD 2023 analysis across 10 selected countries, 1990–2023Archives of Gerontology and Geriatrics, 2026
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023The Lancet, 2025
- Cancer survival statistics in China 2019–2021: a multicenter, population-based studyJournal of the National Cancer Center, 2024
- Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Cancer incidence and mortality in China, 2022Journal of the National Cancer Center, 2024
- A meta-analysis of the prevalence of Low Anterior Resection Syndrome and systematic review of risk factorsInternational Journal of Surgery, 2018
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statementThe Lancet, 2016
- Estimating average annual per cent change in trend analysisStatistics in Medicine, 2009
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000